Almirall SA (ALMRY)
14.28
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Almirall Net Income (Quarterly) : 28.25M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.25M |
| March 31, 2016 | 23.93M |
| December 31, 2015 | 63.32M |
| September 30, 2015 | 16.15M |
| June 30, 2015 | 17.65M |
| March 31, 2015 | 47.53M |
| December 31, 2014 | 501.41M |
| September 30, 2014 | 31.09M |
| June 30, 2014 | 11.67M |
| March 31, 2014 | 14.51M |
| December 31, 2013 | -75.83M |
| September 30, 2013 | 5.600M |
| June 30, 2013 | 9.655M |
| March 31, 2013 | 13.43M |
| December 31, 2012 | -19.72M |
| September 30, 2012 | 81.11M |
| June 30, 2012 | 11.10M |
| March 31, 2012 | 24.27M |
| December 31, 2011 | -6.239M |
| September 30, 2011 | 29.65M |
| June 30, 2011 | 54.16M |
| Date | Value |
|---|---|
| March 31, 2011 | 42.55M |
| December 31, 2010 | -3.221M |
| September 30, 2010 | 44.77M |
| June 30, 2010 | 45.31M |
| March 31, 2010 | 69.83M |
| December 31, 2009 | 15.87M |
| September 30, 2009 | 53.64M |
| June 30, 2009 | 54.63M |
| March 31, 2009 | 82.50M |
| December 31, 2008 | 4.582M |
| September 30, 2008 | 69.68M |
| June 30, 2008 | 62.85M |
| March 31, 2008 | 69.19M |
| December 31, 2007 | 7.698M |
| September 30, 2007 | 45.62M |
| June 30, 2007 | 57.86M |
| March 31, 2007 | 66.18M |
| December 31, 2006 | 133.43M |
| June 30, 2006 | 62.22M |
| March 31, 2006 | 54.50M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 87.12M |
| Eli Lilly & Co. | 7.095B |
| AstraZeneca PLC | 3.076B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 365.79M |
| Total Expenses (Quarterly) | 337.53M |
| Enterprise Value | 2.914B |
| Gross Profit Margin (Quarterly) | 64.43% |
| Profit Margin (Quarterly) | 7.72% |
| Earnings Yield | 2.23% |
| Operating Earnings Yield | 3.62% |
| Normalized Earnings Yield | 2.173 |